Clinical trials
Observational Hyperbilirubinemia, Neonatal trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2013 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Unknown status | 6 |
| Not yet recruiting | 3 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nanjing Medical University | 3 |
| University of Oxford | 3 |
| InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company | 2 |
| National Taiwan University Hospital | 2 |
| University of Patras | 2 |
| Ankara Training and Research Hospital | 1 |
| Assiut University | 1 |
| George Washington University | 1 |
| Guangzhou Women and Children's Medical Center | 1 |
| Hacettepe University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperbilirubinemia, Neonatal | 32 |
| Hyperbilirubinemia | 11 |
| Jaundice, Neonatal | 7 |
| Jaundice | 3 |
| Disease | 2 |
| Colonic Neoplasms | 1 |
| Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 1 |
| Erythroblastosis, Fetal | 1 |
| Hemolysis | 1 |
| Infant, Premature, Diseases | 1 |
Trials
Showing 26 to 32 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.